Testosterone undecanoate

DB13946ApprovedInvestigationalSmall moleculeAndrogens

Testosterone undecanoate is an androgen indicated for testosterone replacement therapy in adult males with primary hypogonadism and hypogonadotropic hypogonadism. Testosterone undecanoate is the ester prodrug of testosterone and has a mid-chain fatty acid at the carbon 17β position.

Chemical structure of Testosterone undecanoate
Mechanism
Curator reviewed · 5 references
Primary indication
Testosterone undecanoate is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.Curator reviewed · 2 structured indications
Formula / weight
C30H48O3 · 456.711 g/mol (avg)
First approval
Canada, 2009 · United States, 2014
Also known as
Testosterone undeconate · Testosterone undecylate
Code names
BAY 86-5037 · BRN 3176734 · CLR-610 · ORG-538
Brand names
  • Aveed
  • Jatenzo
  • Kyzatrex
  • Tlando
  • Undecatrex

Resolves to

Clinical / RWD
Structure
InChIKeyUDSFVOAUHKGBEK-CNQKSJKFSA-NSMILESCCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
Targets

What you can answer from here — as of May 03, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
10TransportersSubstrate / inhibitor direction, not just membership
Listed above
1,227Drug interactionsStructured to mechanism, not free text
Sign in
68Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
5ContraindicationsEach with its own population and attribute set
Sign in
46Marketed productsAcross 10 countries and 30 labellers
Sign in
60+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Testosterone undecanoate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account